Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
A2ML1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
VENTX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SH3D21 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
RGCC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC286359 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CACNA1G - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM175 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYP3A5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RIMBP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEMA3B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TACSTD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POU5F1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GLYCTK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRPF40A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on